Cellerant Therapeutics, Inc. Announces Timothy Fong As Vice President Of Cellular Technologies And Jagath Reddy Junutula As Vice President Of Antibody Discovery & Development
5/12/2014 7:17:29 AM
Cellerant Therapeutics, Inc., a biotechnology company developing novel hematopoietic stem cell-based cellular and antibody therapies for blood disorders and cancer, announced that it has strengthened its senior management team with the appointments of Timothy Fong, Ph.D., as Vice President of Cellular Technologies and Jagath Reddy Junutula, Ph.D., as Vice President of Antibody Discovery & Development.
Help employers find you! Check out all the jobs and post your resume.
comments powered by